Skip to content

Insider · CIK 0002001963

Jacob P Lalezari

ceoofficer

Files at CYDY (CytoDyn Inc.). First filing -, latest -.

Jacob P Lalezari files SEC Form 4 as CEO at CYDY (CytoDyn Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Jacob P Lalezari has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 20, 2026CYDY
CytoDyn Inc.
AGrant or award
Non-qualified stock option (right to buy)derivative
+4,874,691$0.00$04,874,691Mar 24, 2026
Oct 28, 2024CYDY
CytoDyn Inc.
AGrant or award
Non-qualified stock option (right to buy)derivative
+3,000,000$0.00$03,000,000Oct 30, 2024

Questions about Jacob P Lalezari

Answered from the filings on this page, as of the latest one.

Is Jacob P Lalezari buying or selling?

Jacob P Lalezari has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Jacob P Lalezari's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jacob P Lalezari has 0.

Where does Jacob P Lalezari file Form 4?

Jacob P Lalezari has filed Form 4 at CYDY (CytoDyn Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.